Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | BUB1 | O43683 | 1/20 | 0.40 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.35 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8269671 | 0.89 | HSP90AA1 (0.43) | HSP90AA1HSP90AB1BCHEBUB1PIK3R1 | |
| SCHEMBL24781747 | 0.86 | HSP90AA1 (0.41) | HSP90AA1HSP90AB1BCHEBUB1PIK3R1 | |
| SCHEMBL24781751 | 0.84 | HSP90AA1 (0.42) | HSP90AA1HSP90AB1BCHEBUB1PIK3R1 | |
| SCHEMBL16268455 | 0.81 | HSP90AA1 (0.39) | HSP90AA1HSP90AB1BCHEBUB1PIK3R1 | |
| SCHEMBL13346521 | 0.80 | HSP90AA1 (0.40) | HSP90AA1HSP90AB1BCHEBUB1PIK3R1 | |
| SCHEMBL2879972 | 0.78 | NR1H2 (0.42) | HSP90AA1HSP90AB1PIK3R1PIK3CATNK2 | |
| SCHEMBL1442828 | 0.78 | HSP90AA1 (0.42) | HSP90AA1HSP90AB1BCHEBUB1PIK3R1 | |
| SCHEMBL163016 | 0.77 | HSP90AA1 (0.47) | HSP90AA1HSP90AB1BCHEBUB1PIK3R1 | |
| SCHEMBL2563228 | 0.77 | KMT2A (0.35) | MEN1KMT2A | |
| SCHEMBL4916320 | 0.77 | HSP90AA1 (0.47) | HSP90AA1HSP90AB1BCHEBUB1PIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-118619970-A | Extended porphyrin compound containing benzothiadiazole unit, and preparation method and application thereof | 上海大学 | 2024-09-10 | — | — | CN | claimed |
| CN-117843667-A | Asymmetric fulvene- [ b ] -condensed BODIPY fluorescent compound and preparation method thereof | 中国计量大学 | 2024-04-09 | — | — | CN | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| CN-115093423-A | Synthesis method of naphthoporphyrin with different substituents and preparation method of metal complex thereof | 江苏大学 | 2022-09-23 | — | — | CN | claimed |
| CN-112358493-B | Micromolecular photothermal reagent based on boron-fluorine complex and preparation method and application thereof | 南京林业大学 | 2022-06-21 | — | — | CN | claimed |
| CN-112358493-A | Micromolecular photothermal reagent based on boron-fluorine complex and preparation method and application thereof | 南京林业大学 | 2021-02-12 | — | — | CN | claimed |
| US-8361484-B2 | Polymer systems for lung volume reduction therapy | AERIS THERAPEUTICS, INC. (US) | 2013-01-29 | — | — | US | claimed |
| EP-1831206-B1 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI PHARM INC (US) | 2011-08-24 | — | — | EP | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-20060116402-A1 | N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library | OSI PHARMACEUTICALS, INC. | 2006-06-01 | — | — | US | claimed |
| EP-0641347-A1 | METHOD FOR MAKING A PROLINEBORONATE ESTER | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1995-03-08 | — | — | EP | claimed |
| WO-1993010127-A1 | METHOD FOR MAKING A PROLINEBORONATE ESTER | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1993-05-27 | — | — | WO | claimed |
| EP-4747247-A1 | NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2026-05-27 | — | — | EP | disclosed |
| US-12637468-B2 | Substituted [1,2,4]triazolo[4,3-b]pyridazines as GABAA receptor modulators | Shanghai Simr Biotechnology Co., Ltd. (CN) | 2026-05-26 | — | — | US | disclosed |
| WO-1995016674-A1 | AMINOSULPHONYL-PHENYL-1H-PYRROLE DERIVATIVES, METHOD OF THEIR PREPARATION AND THEIR USE | SMITHKLINE BEECHAM PLC (GB) | 1995-06-22 | — | — | WO | disclosed |
| EP-0641347-A1 | METHOD FOR MAKING A PROLINEBORONATE ESTER | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1995-03-08 | — | — | EP | disclosed |
| WO-1993010127-A1 | METHOD FOR MAKING A PROLINEBORONATE ESTER | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1993-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637468-B2 | Substituted [1,2,4]triazolo[4,3-b]pyridazines as GABAA receptor modulators | GABRA6, GABRA1, GABRB1 | HSP90AA1 3634/4885HSP90AB1 3401/4885BCHE 1862/4885 |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | GFER, MUC1, CTH | HSP90AA1 422/4885HSP90AB1 354/4885BCHE 2492/4885 |
| US-20060116402-A1 | N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library | KIT, CHUK, TNNI3K | HSP90AA1 4298/4885HSP90AB1 3594/4885BCHE 988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.